Cytodyn Inc (CYDY)

[studhoss]

So what if Pfizer already owns a CCR5 monoclonal antibody drug? This one works, either that or we're all going to get a very ugly surprise sometime this month. If it does work why wouldn't Pfizer try to buy it? And if all of the anecdotal evidence is any indication, Leronlimab as going to be the miracle drug of the decade, if not the century. Who knows what Pfizer is going to do? All I'm saying is that it's unreasonable to imagine that they're not looking at buying cytodyn just because they already own a similar drug. There might be a million other reasons why they wouldn't consider making an offer. But that 1 doesn't make sense to me.